Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 2
2015 7
2016 3
2017 2
2020 4
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis of Renal Cell Carcinoma: A Clinician's Perspective.
Albiges L, Fay AP, McKay RR, Kaymakcalan MD, Choueiri TK. Albiges L, et al. Among authors: kaymakcalan md. Surg Pathol Clin. 2015 Dec;8(4):657-62. doi: 10.1016/j.path.2015.08.001. Surg Pathol Clin. 2015. PMID: 26612219 Review.
Cabozantinib Safety With Different Anticoagulants in Patients With Renal Cell Carcinoma.
Shayeb AM, McManus HD, Urman D, Jani C, Zhang T, Dizman N, Meza L, Sivakumar A, Gan CL, Barata P, Bilen MA, Gao X, Heng D, Pal S, Narra R, Kilari D, Kaymakcalan MD, McGregor B, Choueiri TK, McKay RR. Shayeb AM, et al. Among authors: kaymakcalan md. Clin Genitourin Cancer. 2023 Feb;21(1):55-62. doi: 10.1016/j.clgc.2022.10.013. Epub 2022 Nov 3. Clin Genitourin Cancer. 2023. PMID: 36411184
Immune-related adverse events and kidney function decline in patients with genitourinary cancers treated with immune checkpoint inhibitors.
Seethapathy H, Street S, Strohbehn I, Lee M, Zhao SH, Rusibamayila N, Chute DF, Gao X, Michaelson MD, Rahma OE, Choueiri TK, McGregor B, Sonpavde G, Salabao C, Kaymakcalan MD, Wei X, Gupta S, Motwani S, Leaf DE, Reynolds KL, Sise ME. Seethapathy H, et al. Among authors: kaymakcalan md. Eur J Cancer. 2021 Nov;157:50-58. doi: 10.1016/j.ejca.2021.07.031. Epub 2021 Sep 2. Eur J Cancer. 2021. PMID: 34482189
Statins and survival outcomes in patients with metastatic renal cell carcinoma.
McKay RR, Lin X, Albiges L, Fay AP, Kaymakcalan MD, Mickey SS, Ghoroghchian PP, Bhatt RS, Kaffenberger SD, Simantov R, Choueiri TK, Heng DY. McKay RR, et al. Among authors: kaymakcalan md. Eur J Cancer. 2016 Jan;52:155-62. doi: 10.1016/j.ejca.2015.10.008. Epub 2015 Dec 11. Eur J Cancer. 2016. PMID: 26687834
Activity of cabozantinib after immune checkpoint blockade in metastatic clear-cell renal cell carcinoma.
McGregor BA, Lalani AA, Xie W, Steinharter JA, E Bakouny Z, Martini DJ, Fleischer JH, Abou-Alaiwi S, Nassar A, Nuzzo PV, Kaymakcalan MD, Braun DA, Wei XX, Harshman LC, Bilen MA, Choueiri TK. McGregor BA, et al. Among authors: kaymakcalan md. Eur J Cancer. 2020 Aug;135:203-210. doi: 10.1016/j.ejca.2020.05.009. Epub 2020 Jun 27. Eur J Cancer. 2020. PMID: 32599410
18 results